Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25
Cleerly to Present Late-Breaking Findings and Participate in Key ACC.25 Sessions
Cleerly to Present Late-Breaking Findings and Participate in Key ACC.25 Sessions
Cleerly will demonstrate its FDA-cleared heart image analyses using mobile scanners in collaboration with Corazon Imaging and Philips
Collaboration Expands Access to AI Technologies for Early Detection and Personalized Treatment of Coronary Artery Disease
December 4, 2024 (DENVER) – TodayCleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series C...
Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.
<div style="padding:56.25% 0 0 0; position:relative;"><iframe src="https://player.vimeo.com/video/708877726?h=61fd91e16c&badge=0&autopause=0&player_id=0&app_id=58479" frameborder="0" allow="autoplay; fullscreen; picture-in-picture" allowfullscreen style="position:absolute; top:0;left:0; width:100%; height:100%;" title="Cleerly / Beats"></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>